12 Consumer Discretionary Stocks Moving In Monday’s Pre-Market Session

Gainers Pinstripes Holdings (NYSE:PNST) shares increased by 18.6% to $3.38 during Monday’s pre-market session. The market value of…

Gainers

  • Pinstripes Holdings (NYSE:PNST) shares increased by 18.6% to $3.38 during Monday’s pre-market session. The market value of their outstanding shares is at $135.4 million.
  • CarParts.com (NASDAQ:PRTS) stock increased by 9.37% to $1.4. The market value of their outstanding shares is at $79.3 million.
  • Worksport (NASDAQ:WKSP) shares moved upwards by 9.37% to $0.98. The company’s market cap stands at $23.5 million.
  • Golden Heaven Group Hldgs (NASDAQ:GDHG) stock moved upwards by 8.89% to $0.36. The market value of their outstanding shares is at $18.8 million.
  • Boqii Holding (AMEX:BQ) shares moved upwards by 8.3% to $0.35. The company’s market cap stands at $1.6 million.
  • Li Auto (NASDAQ:LI) stock moved upwards by 7.64% to $30.14. The market value of their outstanding shares is at $29.9 billion.

Losers

  • Bowlero (NYSE:BOWL) stock declined by 9.9% to $11.25 during Monday’s pre-market session. The company’s market cap stands at $1.6 billion. As per the news, the Q3 earnings report came out today.
  • Visionary Holdings (NASDAQ:GV) shares decreased by 7.71% to $0.25. The company’s market cap stands at $12.8 million.
  • Amesite (NASDAQ:AMST) stock fell 7.28% to $3.07. The market value of their outstanding shares is at $7.8 million.
  • Luminar Technologies (NASDAQ:LAZR) stock declined by 7.15% to $1.56. The market value of their outstanding shares is at $695.0 million.
  • GameStop (NYSE:GME) shares decreased by 6.32% to $15.43. The company’s market cap stands at $4.7 billion.
  • Stitch Fix (NASDAQ:SFIX) shares decreased by 6.12% to $2.15. The market value of their outstanding shares is at $258.3 million.
    See Also: www.benzinga.com/money/best-consumer-cyclical-stocks/

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

What’s Going On With Molecular Templates Stock?

Molecular Templates shares are volatile Tuesday after the company presented interim data from MT-6402 Phase I study in patients with PD-L1+ solid tumors. Molecular Templates said the findings show that MT-6402 acts uniquely from other approved checkpoint agents and was well-tolerated with no drug-related Grade 4 or Grade 5 adverse events observed. "We are excited to see objective responses in heavily pre-treated, checkpoint-experienced, head and neck cancer patients, a setting with high unmet medical need," said CEO Eric Poma.

MTEM